Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
Conditions: Melanoma Interventions: Drug: Ipilimumab; Drug: Nivolumab; Drug: Nivolumab Sponsors: The Netherlands Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Melanoma | Netherlands Health | Research | Skin Cancer | Yervoy